• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.滤泡型甲状腺乳头状癌是一种独特的临床实体:基于人群的 10740 例病例研究。
Thyroid. 2013 Oct;23(10):1263-8. doi: 10.1089/thy.2012.0453. Epub 2013 Sep 11.
2
A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.一种用于术前鉴别滤泡状甲状腺癌与甲状腺乳头状癌滤泡变异型的床边风险计算器。
World J Surg. 2015 Dec;39(12):2928-34. doi: 10.1007/s00268-015-3192-4.
3
Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.经典型和滤泡型乳头状甲状腺癌的组织病理学特征及预后比较
J Endocrinol Invest. 2015 Dec;38(12):1327-34. doi: 10.1007/s40618-015-0376-6. Epub 2015 Aug 18.
4
Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.滤泡型甲状腺癌的临床行为:表现和生存。
Laryngoscope. 2010 Apr;120(4):712-6. doi: 10.1002/lary.20828.
5
Risk-profile and outcome of small papillary and follicular thyroid carcinomas (<or=1 cm).微小乳头状和滤泡状甲状腺癌(≤1厘米)的风险特征及预后
Nuklearmedizin. 2008;47(5):188-93. doi: 10.3413/nukmed-0147.
6
Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.36725例患者中乳头状甲状腺癌和滤泡状甲状腺癌生存率的比较。
Ann Otol Rhinol Laryngol. 2014 Feb;123(2):94-100. doi: 10.1177/0003489414523563.
7
Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study.包裹性经典型和滤泡型甲状腺乳头状癌:临床病理比较研究。
Endocr Pract. 2010 Nov-Dec;16(6):952-9. doi: 10.4158/EP10060.OR.
8
Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.在考虑年龄、肿瘤直径、侵袭性生长和转移等因素时,组织学不影响分化型甲状腺癌的预后。
Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21.
9
[Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].[国际抗癌联盟/美国癌症联合委员会现行的TNM系统:对分化型甲状腺癌的预后意义]
Chirurg. 2012 Jul;83(7):646-51. doi: 10.1007/s00104-011-2216-3.
10
Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.超声在预测甲状腺滤泡型乳头状癌肿瘤侵袭性中的作用。
Thyroid. 2017 Sep;27(9):1177-1184. doi: 10.1089/thy.2016.0677. Epub 2017 Aug 7.

引用本文的文献

1
Beyond Surgical Limits: A Case Report of Follicular Variant of Papillary Thyroid Carcinoma With Persistent Disease Despite Aggressive Surgical Management.超越手术极限:一例滤泡型乳头状甲状腺癌病例报告,尽管采取了积极的手术治疗仍存在持续性疾病
Cureus. 2025 Apr 9;17(4):e81978. doi: 10.7759/cureus.81978. eCollection 2025 Apr.
2
Investigation into the Use of Surufatinib and Donafenib as Novel Multi-Kinase Inhibitors Therapeutic Agents in Managing Advanced Differentiated Thyroid Cancer: A Systematic Review.索凡替尼和多纳非尼作为新型多激酶抑制剂治疗晚期分化型甲状腺癌的应用研究:一项系统评价
Biomedicines. 2025 Mar 20;13(3):752. doi: 10.3390/biomedicines13030752.
3
Papillary Thyroid Carcinoma Metastasis to the Epidural Space: A Case Report and Literature Review.甲状腺乳头状癌转移至硬膜外间隙:1例报告及文献复习
Cureus. 2025 Jan 30;17(1):e78243. doi: 10.7759/cureus.78243. eCollection 2025 Jan.
4
Nodular Goiter as the Presenting Symptom of DICER1 Tumor Predisposition Syndrome.结节性甲状腺肿作为DICER1肿瘤易感性综合征的首发症状
Cureus. 2025 Jan 18;17(1):e77621. doi: 10.7759/cureus.77621. eCollection 2025 Jan.
5
Assessing the Rise in Papillary Thyroid Cancer Incidence: A 38-Year Australian Study Investigating WHO Classification Influence.评估甲状腺乳头状癌发病率的上升:一项为期38年的澳大利亚研究,调查世界卫生组织分类的影响。
J Epidemiol Glob Health. 2025 Jan 27;15(1):9. doi: 10.1007/s44197-025-00354-5.
6
PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer.程序性死亡受体配体1(PD-L1)的表达在不同类型的甲状腺癌中有所不同,并且与间变性甲状腺癌患者无进展生存期(PFS)缩短相关。
Cancers (Basel). 2024 Oct 28;16(21):3632. doi: 10.3390/cancers16213632.
7
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms.使用列线图评估分化型甲状腺癌的碘 131 治疗长期疗效。
Sci Rep. 2024 Oct 7;14(1):23349. doi: 10.1038/s41598-024-72002-0.
8
MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.微小RNA表达谱分析——甲状腺乳头状癌亚型的潜在分子鉴别
Biomedicines. 2024 Jan 9;12(1):136. doi: 10.3390/biomedicines12010136.
9
Cancer-associated fibroblasts in papillary thyroid carcinoma.甲状腺乳头状癌中的癌相关成纤维细胞。
Clin Exp Med. 2023 Oct;23(6):2209-2220. doi: 10.1007/s10238-023-00998-2. Epub 2023 Jan 30.
10
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis.分化型甲状腺癌肺转移患者的生存预后因素:一项系统评价和荟萃分析。
Front Oncol. 2022 Dec 15;12:990154. doi: 10.3389/fonc.2022.990154. eCollection 2022.

本文引用的文献

1
Impact of lymph node ratio on survival in papillary thyroid cancer.淋巴结比率对甲状腺乳头状癌生存的影响。
Ann Surg Oncol. 2013 Jun;20(6):1906-11. doi: 10.1245/s10434-012-2802-8. Epub 2012 Dec 23.
2
What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification.如果许多滤泡型甲状腺乳头状癌并非恶性肿瘤,将会怎样?滤泡型甲状腺乳头状癌的回顾与一种新分类法的提出。
Endocr Pract. 2011 Sep-Oct;17(5):768-87. doi: 10.4158/EP10407.RA.
3
Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.所有甲状腺微小乳头状癌都应积极治疗吗?对 18445 例病例的分析。
Ann Surg. 2011 Oct;254(4):653-60. doi: 10.1097/SLA.0b013e318230036d.
4
Papillary thyroid carcinoma variants.甲状腺乳头状癌变体
Head Neck Pathol. 2011 Mar;5(1):51-6. doi: 10.1007/s12105-010-0236-9. Epub 2011 Jan 8.
5
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.根据滤泡型甲状腺癌的组织学亚型(包裹型与浸润型)进行分子基因分型,揭示了独特的 BRAF 和 RAS 突变模式。
Mod Pathol. 2010 Sep;23(9):1191-200. doi: 10.1038/modpathol.2010.112. Epub 2010 Jun 4.
6
Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.胸腺神经内分泌肿瘤:SEER 数据库 160 例分析。
Ann Surg. 2010 Jun;251(6):1117-21. doi: 10.1097/SLA.0b013e3181dd4ec4.
7
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.1988 - 2005年美国分化型甲状腺癌发病率上升
Cancer. 2009 Aug 15;115(16):3801-7. doi: 10.1002/cncr.24416.
8
Two patients with highly aggressive macrofollicular variant of papillary thyroid carcinoma.两名患有高侵袭性甲状腺乳头状癌大滤泡变体的患者。
Thyroid. 2009 Apr;19(4):413-6. doi: 10.1089/thy.2008.0178.
9
Contralateral papillary thyroid cancer: does size matter?对侧甲状腺乳头状癌:大小重要吗?
Am J Surg. 2009 Mar;197(3):342-7. doi: 10.1016/j.amjsurg.2008.09.011.
10
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).甲状腺微小乳头状癌:106例临床病理研究,重点关注其形态学亚型(组织学生长模式)
Thyroid. 2009 Feb;19(2):119-27. doi: 10.1089/thy.2008.0303.

滤泡型甲状腺乳头状癌是一种独特的临床实体:基于人群的 10740 例病例研究。

Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.

机构信息

Section of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health , Madison, Wisconsin.

出版信息

Thyroid. 2013 Oct;23(10):1263-8. doi: 10.1089/thy.2012.0453. Epub 2013 Sep 11.

DOI:10.1089/thy.2012.0453
PMID:23477346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3787730/
Abstract

BACKGROUND

Follicular variant of papillary thyroid carcinoma (FV-PTC) has been increasingly diagnosed in recent years. However, little is known about its clinical behavior. The purpose of this study was to determine the disease characteristics of FV-PTC, and to compare it with classical papillary thyroid carcinoma (C-PTC) and follicular thyroid carcinoma (FTC).

METHODS

All cases of C-PTC, FV-PTC, and FTC larger than 1 cm in the Surveillance, Epidemiology and End Results (SEER) Cancer Database from 1988 to 2007 were identified. Tumor behavior and patient survival were compared among these three groups. Different risk factors for disease-specific mortality in each group were evaluated by multivariate analysis.

RESULTS

More than 36,000 surgical cases were identified, including 21,796 C-PTCs, 10,740 FV-PTCs, and 3958 FTCs. Extrathyroidal extension and lymph-node metastases were more common in FV-PTC than in FTC, but significantly less common than in C-PTC (p<0.0001). Distant metastasis rates were present in 2% of patients with FV-PTC, in 1% with C-PTC, and in 4% with FTC (p<0.0001). The 10-year disease-specific survival for patients with FV-PTC was 98%, similar to C-PTC (97%) but better than FTC (94%, p<0.0001). Being over the age of 45 years remained a strong risk factor for disease-specific mortality in both FV-PTC and C-PTC, while the presence of extrathyroidal extension and distant metastases were stronger predictors of disease-specific mortality in FV-PTC than in C-PTC.

CONCLUSIONS

FV-PTC is a common variant of PTC. Its clinical behavior is unique and represents an intermediate entity with clinical features that are between C-PTC and FTC. Interestingly, despite the variations in clinical behavior, the long-term outcome of these patients remains excellent and similar to C-PTC.

摘要

背景

滤泡型甲状腺癌(FV-PTC)在近年来的诊断率逐渐升高。然而,人们对其临床行为知之甚少。本研究旨在确定 FV-PTC 的疾病特征,并将其与经典型甲状腺乳头状癌(C-PTC)和滤泡状甲状腺癌(FTC)进行比较。

方法

从 1988 年至 2007 年的监测、流行病学和最终结果(SEER)癌症数据库中确定了 C-PTC、FV-PTC 和大于 1cm 的 FTC 的所有病例。比较三组之间的肿瘤行为和患者生存情况。通过多变量分析评估每组疾病特异性死亡率的不同危险因素。

结果

共确定了 36000 多例手术病例,包括 21796 例 C-PTC、10740 例 FV-PTC 和 3958 例 FTC。FV-PTC 的甲状腺外侵犯和淋巴结转移比 FTC 更常见,但明显少于 C-PTC(p<0.0001)。FV-PTC 患者的远处转移率为 2%,C-PTC 为 1%,FTC 为 4%(p<0.0001)。FV-PTC 患者的 10 年疾病特异性生存率为 98%,与 C-PTC(97%)相似,但优于 FTC(94%,p<0.0001)。年龄超过 45 岁仍然是 FV-PTC 和 C-PTC 疾病特异性死亡的强烈危险因素,而甲状腺外侵犯和远处转移的存在是 FV-PTC 疾病特异性死亡的预测因素,比 C-PTC 更强。

结论

FV-PTC 是 PTC 的常见变体。其临床行为是独特的,代表了一种介于 C-PTC 和 FTC 之间的中间实体。有趣的是,尽管临床行为存在差异,但这些患者的长期预后仍然很好,与 C-PTC 相似。